Recent Updates
Recently added Catalysts
TPST Positive Sentiment Score: 70/100

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

Monday, November 25, 2024 1 min read
Key Takeaway: Tempest Therapeutics, Inc. (Nasdaq: TPST) announced that its senior management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024. The conference will provide a platform for discussion about their targeted and immune-mediated therapeutics in cancer treatment. As a clinical-stage biotechnology company, Tempest is focused on advancing its diverse portfolio of small molecule product candidates. This engagement could be pivotal for attracting investor interest and showcasing their innovative approaches in oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable healthcare conference may enhance visibility.
  • Engagement in dialogue about innovative cancer therapeutics.
  • Opportunity to showcase their research advancements to investors.

Full Press Release Details

BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that members of senior management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 9:00 a.m. ET.
To access the live or archived recording of the discussion, please visit the investor section of the Tempest website at https://ir.tempesttx.com.
About Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest is headquartered in Brisbane, California. More information about Tempest can be found on the company’s website at www.tempesttx.com.
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com
_______________________________
i If approved by the FDA

Frequently Asked Questions

What is the focus of Tempest Therapeutics?

Tempest Therapeutics develops targeted and immune-mediated therapeutics to combat cancer.

When will Tempest's fireside chat take place?

The fireside chat is scheduled for December 3, 2024, at 9:00 a.m. ET.

Where can I access Tempest's fireside chat recording?

The live or archived recording is available in the investor section of Tempest's website.

What types of therapies does Tempest develop?

Tempest develops small molecule therapies with tumor-targeted and immune-mediated action.

Where is Tempest Therapeutics located?

Tempest Therapeutics is headquartered in Brisbane, California.

Tags: TPST Viatris Investor Conferences Healthcare Tempest Therapeutics Piper Sandler healthcare conference cancer therapeutics
Last updated: Nov 25, 2024